Exablate Prime is the newest version of the flagship Exablate Neuro platform
Could reduce sample sizes and accelerate process for approval of cancer therapies
Measures each individual X-ray that passes through the patient
Society of Interventional Radiology (SIR) appoints president for 2025-2026
New technology only takes a few seconds to scan tumor
Purchasing insights from the experts at MD Buyline
ViewRay appoints new member to board of directors
Preventing unnecessary scans could potentially save billions of dollars
Will eliminate radiation safety risks and mechanical limitations
Seeks to increase clinical labor staff wages in 2022 MPFS and HOPPS-ASC final rules
A novel way of precisely targeting the tumor
The biggest CT stories of the year from our Daily News online
Aims to treat 1,000 patients annually with two-room Varian ProBeam
New treatment releases are driving the need for more precise patient evaluation tools
Actimab-A is an alpha-emitting radiotherapeutic targeting CD33, a protein commonly found on cancer cells in acute myeloid leukemia
Will include radiation oncology, medical oncology, and PET/CT diagnostic scanning
Q&A with Dr. James Cox.
Adds SoniVie's TIVUS intravascular ultrasound to interventional cardiology portfolio
Affiliations with Rady Children's Hospital, UC San Diego Health System announced.
